Golemovic M, Skific M, Haluzan D, Pavic P, Golubic Cepulic B
Department of Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia.
Department of Surgery, Division for Vascular Surgery, University Hospital Centre Zagreb, Zagreb, Croatia.
Cell Tissue Bank. 2022 Dec;23(4):807-824. doi: 10.1007/s10561-022-09992-6. Epub 2022 Feb 7.
The Croatian Cardiovascular Tissue Bank (CTB) was established in June 2011. Activities managed by CTB are processing of heart valves and blood vessels, as well as quality control, storage, medical release and distribution of allografts. The aim of this report is to present CTB's vascular tissue activities and retrospectively evaluate the outcomes of their use in the University Hospital Centre Zagreb. Between June 2011 and July 2021, 90 vascular allografts (VAs) from 55 donors after brain death were referred to CTB. Only 54% of VAs met the tissue quality requirements while 46% of tissues were discarded. The most frequent reasons for discard were unacceptable morphology and initial microbiological contamination. Altogether 42 VAs were released for transplantation and 37 of them were used in 27 surgical procedures. The most common indication for surgery was prosthetic graft or stent infection. According to the anatomic position of vascular reconstruction, patients were divided in the aortic and peripheral reconstruction group. A total of 23 patients were treated. In the aortic reconstruction group 58% of patients did not experience any graft-related complications. In the group of patients who underwent peripheral reconstruction significant incidence of reinfection was observed highlighting it as a major graft-related complication. Despite the small patient groups and limited duration of follow-up, presented clinical outcomes provide valuable information on the efficacy of vascular allografts. Additional clinical results collected on a larger patient groups and comparison to other reconstructive treatment options are necessary.
克罗地亚心血管组织库(CTB)成立于2011年6月。CTB管理的活动包括心脏瓣膜和血管的处理,以及同种异体移植物的质量控制、储存、医学放行和分发。本报告的目的是介绍CTB的血管组织活动,并回顾性评估其在萨格勒布大学医院中心使用的结果。2011年6月至2021年7月期间,55例脑死亡供体的90个血管同种异体移植物(VA)被送至CTB。只有54%的VA符合组织质量要求,46%的组织被丢弃。最常见的丢弃原因是形态不可接受和初始微生物污染。共有42个VA被放行用于移植,其中37个用于27例外科手术。最常见的手术指征是人工血管移植物或支架感染。根据血管重建的解剖位置,患者被分为主动脉重建组和外周重建组。共有23例患者接受治疗。在主动脉重建组中,58%的患者未出现任何与移植物相关的并发症。在外周重建组的患者中,观察到再感染的发生率较高,这突出表明其是主要的与移植物相关的并发症。尽管患者群体较小且随访时间有限,但所呈现的临床结果为血管同种异体移植物的疗效提供了有价值的信息。有必要收集更大患者群体的更多临床结果,并与其他重建治疗选择进行比较。